220 related articles for article (PubMed ID: 23863506)
1. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
[TBL] [Abstract][Full Text] [Related]
2. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.
Quan FS; Kim YC; Vunnava A; Yoo DG; Song JM; Prausnitz MR; Compans RW; Kang SM
J Virol; 2010 Aug; 84(15):7760-9. PubMed ID: 20484519
[TBL] [Abstract][Full Text] [Related]
3. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.
Song JM; Kim YC; Barlow PG; Hossain MJ; Park KM; Donis RO; Prausnitz MR; Compans RW; Kang SM
Antiviral Res; 2010 Nov; 88(2):244-7. PubMed ID: 20851715
[TBL] [Abstract][Full Text] [Related]
4. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
[TBL] [Abstract][Full Text] [Related]
5. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.
Song JM; Kim YC; Lipatov AS; Pearton M; Davis CT; Yoo DG; Park KM; Chen LM; Quan FS; Birchall JC; Donis RO; Prausnitz MR; Compans RW; Kang SM
Clin Vaccine Immunol; 2010 Sep; 17(9):1381-9. PubMed ID: 20631330
[TBL] [Abstract][Full Text] [Related]
6. Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice.
Quan FS; Vunnava A; Compans RW; Kang SM
PLoS One; 2010 Feb; 5(2):e9161. PubMed ID: 20161790
[TBL] [Abstract][Full Text] [Related]
7. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.
Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Infect Dis; 2010 Jan; 201(2):190-8. PubMed ID: 20017632
[TBL] [Abstract][Full Text] [Related]
8. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
[TBL] [Abstract][Full Text] [Related]
9. Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring.
Esser ES; Pulit-Penaloza JA; Kalluri H; McAllister D; Vassilieva EV; Littauer EQ; Lelutiu N; Prausnitz MR; Compans RW; Skountzou I
Sci Rep; 2017 Jul; 7(1):5705. PubMed ID: 28720851
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
[TBL] [Abstract][Full Text] [Related]
11. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.
Kim YC; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Control Release; 2013 Dec; 172(2):579-88. PubMed ID: 23643528
[TBL] [Abstract][Full Text] [Related]
12. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
J Control Release; 2010 Mar; 142(2):187-95. PubMed ID: 19840825
[TBL] [Abstract][Full Text] [Related]
13. Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination.
Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Jacob J; Prausnitz MR; Compans RW; Skountzou I
J Infect Dis; 2011 Aug; 204(4):582-91. PubMed ID: 21685355
[TBL] [Abstract][Full Text] [Related]
14. Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice.
Shin JH; Park JK; Lee DH; Quan FS; Song CS; Kim YC
PLoS One; 2015; 10(6):e0130684. PubMed ID: 26086590
[TBL] [Abstract][Full Text] [Related]
15. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW
PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
[TBL] [Abstract][Full Text] [Related]
17. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
18. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.
Weldon WC; Martin MP; Zarnitsyn V; Wang B; Koutsonanos D; Skountzou I; Prausnitz MR; Compans RW
Clin Vaccine Immunol; 2011 Apr; 18(4):647-54. PubMed ID: 21288996
[TBL] [Abstract][Full Text] [Related]
19. Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice.
Schneider-Ohrum K; Giles BM; Weirback HK; Williams BL; DeAlmeida DR; Ross TM
Vaccine; 2011 Nov; 29(48):9081-92. PubMed ID: 21963872
[TBL] [Abstract][Full Text] [Related]
20. Improved influenza vaccination in the skin using vaccine coated microneedles.
Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
Vaccine; 2009 Nov; 27(49):6932-8. PubMed ID: 19761836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
